BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 21777580)

  • 1. Quantitative evaluation of SPRR3 expression in esophageal squamous cell carcinoma by qPCR and its potential use as a biomarker.
    de A Simão T; Souza-Santos PT; de Oliveira DS; Bernardo V; Lima SC; Rapozo DC; Kruel CD; Faria PA; Ribeiro Pinto LF; Albano RM
    Exp Mol Pathol; 2011 Oct; 91(2):584-9. PubMed ID: 21777580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of lysyl oxidase is correlated with lymph node metastasis and poor prognosis in esophageal squamous cell carcinoma.
    Sakai M; Kato H; Sano A; Tanaka N; Inose T; Kimura H; Sohda M; Nakajima M; Kuwano H
    Ann Surg Oncol; 2009 Sep; 16(9):2494-501. PubMed ID: 19526206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-142-3p as a potential prognostic biomarker for esophageal squamous cell carcinoma.
    Lin RJ; Xiao DW; Liao LD; Chen T; Xie ZF; Huang WZ; Wang WS; Jiang TF; Wu BL; Li EM; Xu LY
    J Surg Oncol; 2012 Feb; 105(2):175-82. PubMed ID: 21882196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and prognostic significance of RhoA and RhoC gene expression in esophageal squamous cell carcinoma.
    Faried A; Faried LS; Usman N; Kato H; Kuwano H
    Ann Surg Oncol; 2007 Dec; 14(12):3593-601. PubMed ID: 17896152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expression of ERK1/2 MAPK signaling transduction pathway in esophageal cancers in Kazakh patients].
    Zheng ST; Liu T; Middottuersun A; Huo Q; Liu Q; Huang CG; Feng JG; Lü GD; Wang X; Lin RY; Sheyhidin I; Lu XM
    Zhonghua Zhong Liu Za Zhi; 2011 Jun; 33(6):421-5. PubMed ID: 21875481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of fascin overexpression in human esophageal squamous cell carcinoma.
    Hashimoto Y; Ito T; Inoue H; Okumura T; Tanaka E; Tsunoda S; Higashiyama M; Watanabe G; Imamura M; Shimada Y
    Clin Cancer Res; 2005 Apr; 11(7):2597-605. PubMed ID: 15814639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The overexpression of caveolin-1 and caveolin-2 correlates with a poor prognosis and tumor progression in esophageal squamous cell carcinoma.
    Ando T; Ishiguro H; Kimura M; Mitsui A; Mori Y; Sugito N; Tomoda K; Mori R; Harada K; Katada T; Ogawa R; Fujii Y; Kuwabara Y
    Oncol Rep; 2007 Sep; 18(3):601-9. PubMed ID: 17671707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Profiling of differentially expressed cancer-related genes in esophageal squamous cell carcinoma (ESCC) using human cancer cDNA arrays: overexpression of oncogene MET correlates with tumor differentiation in ESCC.
    Hu YC; Lam KY; Law S; Wong J; Srivastava G
    Clin Cancer Res; 2001 Nov; 7(11):3519-25. PubMed ID: 11705871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered expression of ezrin in esophageal squamous cell carcinoma.
    Zeng H; Xu L; Xiao D; Zhang H; Wu X; Zheng R; Li Q; Niu Y; Shen Z; Li E
    J Histochem Cytochem; 2006 Aug; 54(8):889-96. PubMed ID: 16585385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue microarray analysis reveals a tight correlation between protein expression pattern and progression of esophageal squamous cell carcinoma.
    Xue LY; Hu N; Song YM; Zou SM; Shou JZ; Qian LX; Ren LQ; Lin DM; Tong T; He ZG; Zhan QM; Taylor PR; Lu N
    BMC Cancer; 2006 Dec; 6():296. PubMed ID: 17187659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased expression of RUNX3 is correlated with tumor progression and poor prognosis in patients with esophageal squamous cell carcinoma.
    Sugiura H; Ishiguro H; Kuwabara Y; Kimura M; Mitsui A; Mori Y; Ogawa R; Katada T; Harata K; Fujii Y
    Oncol Rep; 2008 Mar; 19(3):713-9. PubMed ID: 18288406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dysregulated expression of HOX and ParaHOX genes in human esophageal squamous cell carcinoma.
    Takahashi O; Hamada J; Abe M; Hata S; Asano T; Takahashi Y; Tada M; Miyamoto M; Kondo S; Moriuchi T
    Oncol Rep; 2007 Apr; 17(4):753-60. PubMed ID: 17342311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Dysregulation of Annexin II expression in esophageal squamous cell cancer and adjacent tissues from a high-incidence area for esophageal cancer in Henan province].
    Qi YJ; Wang LD; Jiao XY; Feng XS; Fan ZM; Gao SS; He X; Li JL; Chang FB
    Ai Zheng; 2007 Jul; 26(7):730-6. PubMed ID: 17626749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumorigenic role of podoplanin in esophageal squamous-cell carcinoma.
    Rahadiani N; Ikeda J; Makino T; Tian T; Qiu Y; Mamat S; Wang Y; Doki Y; Aozasa K; Morii E
    Ann Surg Oncol; 2010 May; 17(5):1311-23. PubMed ID: 20066519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The oncogenetic role of microRNA-31 as a potential biomarker in oesophageal squamous cell carcinoma.
    Zhang T; Wang Q; Zhao D; Cui Y; Cao B; Guo L; Lu SH
    Clin Sci (Lond); 2011 Nov; 121(10):437-47. PubMed ID: 21658006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An inducible short-hairpin RNA vector against osteopontin reduces metastatic potential of human esophageal squamous cell carcinoma in vitro and in vivo.
    Ito T; Hashimoto Y; Tanaka E; Kan T; Tsunoda S; Sato F; Higashiyama M; Okumura T; Shimada Y
    Clin Cancer Res; 2006 Feb; 12(4):1308-16. PubMed ID: 16489088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The differential expression of SPARC in esophageal squamous cell carcinoma.
    Che Y; Luo A; Wang H; Qi J; Guo J; Liu Z
    Int J Mol Med; 2006 Jun; 17(6):1027-33. PubMed ID: 16685412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive characterization of annexin I alterations in esophageal squamous cell carcinoma.
    Hu N; Flaig MJ; Su H; Shou JZ; Roth MJ; Li WJ; Wang C; Goldstein AM; Li G; Emmert-Buck MR; Taylor PR
    Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6013-22. PubMed ID: 15447985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel gene, RSRC2, inhibits cell proliferation and affects survival in esophageal cancer patients.
    Kurehara H; Ishiguro H; Kimura M; Mitsui A; Ando T; Sugito N; Mori R; Takashima N; Ogawa R; Fujii Y; Kuwabara Y
    Int J Oncol; 2007 Feb; 30(2):421-8. PubMed ID: 17203224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequent methylation-associated silencing of a candidate tumor-suppressor, CRABP1, in esophageal squamous-cell carcinoma.
    Tanaka K; Imoto I; Inoue J; Kozaki K; Tsuda H; Shimada Y; Aiko S; Yoshizumi Y; Iwai T; Kawano T; Inazawa J
    Oncogene; 2007 Sep; 26(44):6456-68. PubMed ID: 17438526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.